Vimy Pharmaceuticals Corp.TSXV: VIMY

Vimy Pharmaceuticals Corp. (VIMY) Opens the Market

· Issued by Vimy Pharmaceuticals Corp. via Newsfile

Summary by 6ix AI

Executives of Vimy Pharmaceuticals Corp., a Canadian generic pharmaceutical company, joined Omar Khafagy, Head, Client Success, Toronto Stock Exchange and TSX Venture Exchange, to open the market to celebrate the company's new listing on the TSX Venture Exchange (ticker VIMY).

Key details

  • Those taking part included co-founders David Suchon (CEO), Farris Smith (President) and Chris Burkett (Chief Operating Officer), along with members of the company's executive team.
  • Vimy Pharma says it is committed to improving access to affordable medicine through expanding domestic pharmaceutical manufacturing capacity, and is advancing a portfolio of essential medicines as generic pharmaceutical products.

6ix AI wrote this summary from the release below and checked it against the release.

Toronto, Ontario--(Newsfile Corp. - November 17, 2026) - David Suchon, Co-Founder and Chief Executive Officer, Farris Smith, Co-Founder and President and Chris Burkett, Co-Founder and Chief Operating Officer of Vimy Pharmaceuticals Corp. ("Vimy Pharma", or the "Company") (TSXV: VIMY), along with members of the Company's executive team, joined Omar Khafagy, Head, Client Success, Toronto Stock Exchange ("TSX") and TSX Venture Exchange ("TSXV"), to open the market to celebrate the Company's new listing on TSX Venture Exchange.

Watch the video: https://www.youtube.com/watch?v=_KCsQBbOI68

Vimy Pharma is a Canadian pharmaceutical company committed to improving access to affordable medicine through expanding domestic pharmaceutical manufacturing capacity and long-term Canadian supply resilience. Vimy Pharma is advancing a portfolio of essential medicines as generic pharmaceutical products intended to support patients, the healthcare system, and Canada's broader life sciences sector.

Vimy Pharma is led by an experienced management team with expertise spanning pharmaceutical development, manufacturing, regulatory affairs, commercialization, and capital markets, with a shared commitment to building a stronger Canadian pharmaceutical industry.

Vimy Pharma is committed to long-term value creation through disciplined execution and the development of a sustainable domestic pharmaceutical ecosystem that serves patients here at home and abroad, supports healthcare providers and government partners, and enhances Canadian pharmaceutical sovereignty.

MEDIA CONTACT:
Ben Hosein
Investor Relations
Vimy Pharmaceuticals Corp.
+1 416-452-3009
www.VimyPharma.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/324485

View original source (Newsfile)Vimy Pharmaceuticals Corp. on 6ix

Earlier from Vimy Pharmaceuticals

Later from Vimy Pharmaceuticals

All Vimy Pharmaceuticals news releases